Remembering negative events tends to result in more false memories than remembering neutral events, according to Cornell professor of human development Charles Brainerd.
The new research has implications for the accuracy of legal testimony in criminal cases and how interviews and interrogations in violent cases could be better conducted.
"You may not remember the specifics of what happened to you, but boy, do you remember it was negative," said Brainerd. "And that allows you to fill in the blanks with 'memories' of negative events that didn't really happen."
Brainerd is the lead author of a study published in Psychological Science (Vol. 19, No. 9); co-authors include his wife, Valerie Reyna, also a Cornell professor of human development, and colleagues from Brazilian universities.
The researchers conducted experiments in which about 120 participants -- half in Brazil and half in the United States -- were asked to read lists of words that had either positive, negative or neutral connotations. They were then asked to identify which words had been listed. When remembering negative words -- such as mad, sad, rage, temper, ire and wrath -- they were much more likely to be inaccurate and "falsely remember" such unlisted words as anger. When identifying positive words, their memories were much more accurate.
The findings challenge traditional ideas about how emotion affects memory, Brainerd says. "Historically the belief has been that negative events are really pretty easy to remember, that negative emotion creates very distinctive memories. What we found was exactly the opposite. Negative information really tends to distort your memory."
Brainerd calls the phenomenon the Junior Prom Effect; many people find that high school experience negative but intense.
The study has implications for further research on remembering distressing events.
"You can't be sure that what people say is true," Brainerd said. "You have to be very careful, because negative events are prone to distortion."
Provided by Cornell University
Explore further: Adding Veliparib to chemotherapy improved response rates among patients with BRCA-mutant breast cancer